For 25 years, Steven Halpern, editor of TheStockAdvisors.com, has surveyed the main financial newsletter advisors asking for their favorite stocks for the coming year. that scoop is one of 100+ ideas in the Best Stocks for 2008 report.

“The era of personalized medicine is arriving and Genomic Health (NASDAQ: GHDX) is one of the first companies to supply both a successful product and an investment opportunity,” says Dave Dyer in his Dave Dyer’s Newsletter, referring to his more speculative favorite for 2008.

“The company’s genetic pop quiz provides a way to determine whether women with

early stage breast cancer would benefit from chemotherapy. For 70% of citizens with early stage breast cancer, minimally invasive surgery and radiation is all that is needed.

“The other 30% have a more aggressive type of cancer and would benefit from additionally receiving chemotherapy. An objective, quantifiable experiment based on the genetic characteristics of a specific patient can determine with very high probability which group a patient belongs to.

Continue reading Best Stocks for 2008: Genomic Health (GHDX) targets cancer testing

Original post by Steven Halpern

auto insurance tax refinance finance investing student loan consolidation child support income taxes banking real estate